未找到相关数据
China syndrome - a regulatory framework in meltdown?
被引：5
作者：
Jia, Hepeng
机构：
关键词：
D O I：
10.1038/nbt0807-835
中图分类号：
Q81 [生物工程学（生物技术）];
Q93 [微生物学];
学科分类号：
071005 ;
0836 ;
090102 ;
100705 ;
摘要：
When Zheng Xiaoyu took the helm of the Chinese State Food and Drug Administration nine years ago, hopes were high for the modernization of China's regulatory framework. Now those hopes have been dashed with tragic personal consequences for Zheng and allegations of widespread corruption by Chinese officials. Hepeng Jia investigates.
引用
收藏
页码：834 / 836
页数：3
相关论文